Cupps Capital Management, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 181 filers reported holding NEKTAR THERAPEUTICS in Q4 2015. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cupps Capital Management, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2016$2,326,000
-2.4%
135,403
-19.2%
1.01%
+63.5%
Q2 2016$2,384,000
-41.6%
167,553
-43.5%
0.62%
-20.9%
Q1 2016$4,079,000
-30.2%
296,685
-14.5%
0.78%
-5.0%
Q4 2015$5,847,000347,0150.82%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2015
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders